Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,553
Total Claims
$888K
Drug Cost
652
Beneficiaries
$1,363
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+240%
Opioid rate vs peers
8.8% vs 2.6% avg
+28%
Cost per patient vs peers
$1,363 vs $1,068 avg
+6%
Brand preference vs peers
9.5% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 240% above Family Practice peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
8.8%
Opioid Rate
1,365
Opioid Claims
$40K
Opioid Cost
4.3%
Long-Acting Rate
Brand vs Generic
Brand: 1,469 claims · $559K
Generic: 13,987 claims · $323K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 134 | $70K |
| Pimavanserin Tartrate | 25 | $58K |
| Sitagliptin Phosphate | 115 | $47K |
| Semaglutide | 43 | $47K |
| Fluticasone/Umeclidin/Vilanter | 32 | $27K |
| Ipratropium/Albuterol Sulfate | 21 | $25K |
| Linaclotide | 37 | $21K |
| Dapagliflozin Propanediol | 19 | $20K |
| Dulaglutide | 18 | $19K |
| Insulin Nph Hum/Reg Insulin Hm | 11 | $18K |
| Hydrocodone/Acetaminophen | 681 | $16K |
| Mirabegron | 25 | $14K |
| Insulin Detemir | 17 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $13K |
| Tirzepatide | 11 | $12K |
Prescribing Profile
Patient Profile
73
Avg Age
71%
Female
1.40
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data